Clinical Trial

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 31, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is an open-label, prospective observational study in people 18 years of age and older designed to track changes in the dynamics of the respiratory and peripheral blood immune response in people infected with influenza virus and new coronaviruses, and to resolve the characteristics of the virus-induced natural immune response.
Trial Details
NCT Number NCT06667063
Lead Sponsor Zhongnan Hospital
Collaborators: Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
Conditions COVID-19, Influenza
Enrollment 130 participants
Start Date 2024-09-19
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-31